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mouse embryos (a), LPS activated cells (b) were incubated with Mino
(c), Mino loaded in NPs (d).
Conclusions: In this study we demonstrated the selective efﬁcacy of mi-
nocycline loaded in NPs in reducing the inﬂammatory response medi-
ated by microglia/macrophage activation in SCI.
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Introduction: The use of biostructures and bioceramics derived from
the marine environment for several application has been proposed in
the last years by different authors. Examples are the use of different
marine species like coral skeletons, sea urchins and sponges as three
dimensional biomatrices1-3.We have focused on the potential of bioce-
ramics obtained from three marine sponges, Petrosia ﬁcidormis (PET),
Agelas oroides (AG) and Chondrosia reniformis (CR) for biomedical
applications. In vitro bioactivity studies promote the precipitation of
crystals of calcium phosphate (e.g. hydroxyapatite) on the surface of
marine sponge derived bioceramics suggesting these as a new source of
bioactive ceramics for tissue engineering and regenerative medicine
(TERM) applications.
Materials and methods: In these work, Sponge samples were collected
in Mediterranean Sea, namely in Spanish north east coast (Petrosia ﬁci-
formis. and Agelas oroides) and Israeli coast (Chondrosia reniformis). Bi-
oceramics were obtained, after sponge calcination in a furnace at
750!C for 6 hours. In vitro bioactivity of the bioceramics was evaluated
by immersion in simulated body ﬂuid (SBF), for 14 and 21 days. The
structures were observed by SEM and the chemical composition was
evaluated by energy dispersive x-ray spectroscopy (EDS) and Fourier
transform infrared spectroscopy (FTIR). Cytotoxicity studies were also
performed, using the commercial Bioglass 45S5" as reference.
Results: The bioceramics structures obtained after calcination present
different morphological and chemical compositions, as observed by
SEM-EDS (FIG. 1). PET skeleton is a 3D architecture, composed of SiO2
groups. On the other hand the inorganic part of AG and CR is a powder
mainly composed of silicates. However, they also contain Ca and Mg.
The microscopic observation of the ceramics crystals after immersion in
SBF solution for 14 and 21 days disclosed surface crystals, with the typ-
ical cauliﬂower-like shape characteristic of hydroxyapatite, in case of
AG and CR. These crystals are composed of Ca, P and Mg as demon-
strated by EDS analysis. PETon the other hand, did not reveal any crys-
tal precipitation, suggesting no inherent bioactivity. FTIR conﬁrmed the
presence of characteristics peaks of carbonates and phosphates of
hydroxyapatite, nxCO3 and nxPO4, after immersion of the marine ori-
gin ceramics in SBF solution. XRD analysis conﬁrms the crystallo-
graphic planes of hydroxyapatite and some intermediate crystals.
Finally, in vitro test results demonstrate that bioceramics from these
sponges are non-cytotoxic to L929 Cells.
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Figure 1 Images of bioceramics obtained after calcination.
Discussion and conclusions: The results show that bioceramics obtained
from PET sponges do not possess inherent bioactivity on the contrary of
AG and CR, which establish, after 14 days and 21 days of immersion in
SBF solution, the formation of hydroxyapatite crystals on their surface.
Observing the chemical composition of the sponges after calcination,
bioactivity can be explained by the presence of calcium and magnesium
groups, which allow nucleation of crystals. CR and AG ceramics show,
hereafter a bioactive behavior with potential use in TERM applications,
namely towards bone tissues.
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Introduction: Tissue engineering strategies based on endochondral
ossiﬁcation have begun to emerge, utilizing cartilaginous grafts gener-
ated using mesenchymal stem cells (MSCs) as a transient template to
facilitate bone regeneration [1]. Alginate gels have been shown to sup-
port chondrogenesis of MSCs in vitro, and by modifying the architecture
of such hydrogels [2], can potentially be scaled-up to engineer cartilage
grafts to treat large bone defects. The objective of this study was to
explore the capacity of MSC-seeded alginate hydrogels, which are ﬁrst
primed in vitro to undergo chondrogenesis and hypertrophy, to facili-
tate regeneration of two distinct critically-sized orthotopic bone
defects.
Materials and methods: Fisher rat bone marrow MSCs were encapsu-
lated in alginate gel (20x10^6/ml) using custom designed PDMS
molds to generate channeled gels of appropriate dimensions (5 mm
height x 4 mm diameter for femoral defect, 2 mm height x 7 mm
diameter for cranial defect) for implantation into ﬁsher rats. Constructs
(n = 4 per time point) were harvested after 4 and 8 weeks and analy-
sed using microCT and histology to investigate levels of mineralization
and bone deposition. In vivo studies were conducted with full ethical
approval. Statistical differences in bone volume were compared using
t-tests.
Results: Macroscopic observation of the bones retrieved after 4 and
8 weeks indicate that the grafts were well integrated with the sur-
rounding original bone in a repair callus. A signiﬁcant (p < 0.05)
increase in bone formation (as determined by microCT analysis) was
observed within the alginate treated femoral defect group vs. an empty
control as early as 4 weeks, and this trend was observed for all defects
at both 4 and 8 weeks. Histological analysis demonstrated the
ingrowth of some vasculature into the defect as the alginate fragments
degraded, and also demonstrated the formation of new bone along the
surfaces of these fragments.
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